<DOC>
	<DOCNO>NCT00582205</DOCNO>
	<brief_summary>The purpose study evaluate give chemotherapy drug directly abdomen ( belly ) along intravenous administration .</brief_summary>
	<brief_title>Feasibility Trial Intraperitoneal Chemotherapy Ovarian , Fallopian Tube , Primary Peritoneal Carcinoma</brief_title>
	<detailed_description>Giving chemotherapy directly abdomen call intraperitoneal ( IP ) chemotherapy . Because ovarian , fallopian , primary peritoneal uterine cancer spread abdominal cavity , give chemotherapy drug infusion abdominal cavity may result great dose drug reach tumor cell . Intraperitoneal treatment administer implantable peritoneal catheter . These catheter insert peritoneal cavity , tunnel subcutaneous tissue , connect implantable port , place subcutaneous tissue anterior , inferior thorax .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<mesh_term>Uterine Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>Patients stage IA , IB , IC , II , III , IV recurrent platinum sensitive epithelial ovarian carcinoma , fallopian tube carcinoma , primary peritoneal carcinoma , ovarian carcinosarcoma . Histologic subtypes eligible include serous adenocarcinoma , endometrioid adenocarcinoma , mucinous adenocarcinoma , undifferentiated carcinoma , clear cell adenocarcinoma , mixed epithelial carcinoma , transitional cell carcinoma , malignant Brenner 's tumor , adenocarcinoma ( otherwise specify ) , carcinosarcoma . Patients advance endometrial carcinoma , histology , include endometrioid adenocarcinoma , clear cell adenocarcinoma , serous papillary carcinoma . Patients uterine carcinosarcoma stage eligible . Patients epithelial ovarian carcinoma low malignant potential ( borderline carcinoma ) . Patients septicemia , severe infection , acute hepatitis . Patients prior malignancy cancer treatment within last five year .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Ovarian Cancer</keyword>
	<keyword>Fallopian Tube Cancer</keyword>
	<keyword>Primary Peritoneal Carcinoma</keyword>
	<keyword>Uterine Cancer</keyword>
	<keyword>Intraperitoneal Chemotherapy</keyword>
	<keyword>IP Chemotherapy</keyword>
	<keyword>Gynecologic Cancer</keyword>
	<keyword>Women 's Cancer</keyword>
	<keyword>Cisplatin</keyword>
	<keyword>Paclitaxel</keyword>
	<keyword>Recurrent Platinum Sensitive Ovarian Cancer</keyword>
</DOC>